Mini invasive surgery for gastro-esophageal junction tumors: An updated review.

DOI: 10.17605/OSF.IO/WXPYD

 


Vargas-Flores E, González-Jiménez I, Martínez-Vargas VM, Ortíz-Bayliss AB. Mini invasive surgery for gastro-esophageal junction tumors: An updated review. Am J Med Surg. 2020; 2(4). 6-14

From the Division of General surgery and Laparoscopy at Hospital General de Zona 5, Sonora, Mexico. Received on December 1, 2020. Accepted on December 10, 2020. Published on December 17, 2020.

Abstract: While the majority of esophagectomies worldwide are conducted as open procedures, the proliferation of minimally invasive methods is increasing over time. The short-term advantages of minimally invasive esophagectomy in terms of lower morbidity and better quality of life compared to the open approach have become visible in recent years. There are two main approaches in minimally invasive esophagectomy: the transthoracic approach (Accompanied by intrathoracic or cervical anastomosis) or transhiatal esophagectomy (with cervical anastomosis).

MIE (Minimally Invasive esophagectomy) is a healthy procedure with positive oncological outcomes relative to standard open esophagectomy. Minimally invasive surgical techniques are just another therapeutic option for surgical resection of gastroesophageal junction tumors and outcomes are just as good as open procedures when performed by experienced hands.

 

Keywords: Gastroesophageal junction tumors, Gastroesophageal cancer, Gastric cancer, Minimally invasive esophagectomy, Laparoscopic esophagectomy.